全球梅毒免疫测量诊断市场

预计2030年全球梅毒免疫测量诊断市场规模将达4.451亿美元

全球梅毒免疫测量诊断市场规模预计在2024年为3.566亿美元，预计2024年至2030年期间的复合年增长率为3.8%，到2030年将达到4.451亿美元。分析仪是本报告分析的细分市场之一，预计其复合年增长率为3.0%，到分析期结束时规模将达到2.611亿美元。套件和试剂细分市场在分析期间的复合年增长率预计为4.9%。

美国市场规模估计为 9,710 万美元；中国市场预期复合年增长率为 6.8%

美国梅毒免疫测量诊断市场规模预计在2024年达到9,710万美元。作为世界第二大经济体，中国预计到2030年市场规模将达到8,900万美元，在2024-2030年的分析期间内，复合年增长率为6.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.6%和2.9%。在欧洲，预计德国市场的复合年增长率为2.2%。

全球梅毒免疫测量诊断市场—主要趋势与驱动因素摘要

为什么免疫测量测定检测成为梅毒诊断的重点？

梅毒免疫测量测定诊断技术因其高度特异性、扩充性以及能够检测性行为感染感染和潜伏性性行为感染的能力，已成为性行为感染感染 (STI)筛检的基石。这些检测依靠抗原抗体结合来检测梅毒螺旋体，广泛应用于医院、性传染病诊所和公共卫生实验室的常规检测和确认性检测。鑑于梅毒在全球復发，尤其是在高风险族群和爱滋病毒合併感染族群中，扩大其使用尤为重要。

分散式医疗机构正在采用快速即时免疫检测法，以便更快地做出治疗决策，尤其是在资源有限的地区。自动化免疫测量分析仪已成为集中式实验室的标准配置，可进行高通量、多重检测以及其他性传染感染的检测。它们被纳入产前筛检计划，也使其成为预防先天性梅毒的关键。随着政策对早期发现和治疗的重视程度不断提高，免疫检测已成为全球梅毒控制的重中之重。

哪些技术正在提高梅毒免疫测量诊断的准确性和覆盖范围？

免疫测量平台的演进显着提高了分析效能。化学冷光免疫检测(CLIA)、酵素结合免疫吸附检测法(ELISA) 和萤光系统如今在各种疾病阶段均具有优异的灵敏度和特异性。梅毒螺旋体和非梅毒螺旋体抗体的双重检测模式正在整合，以减少假阴性并实现全面的血清学分析。

微型化和微射流使得手持设备能够快速进行免疫测量，无需实验室基础设施，几分钟内即可获得结果。多重免疫检测技术正在开发中，可在单一试剂盒上同时检测梅毒、爱滋病毒和肝炎。此外，人工智慧影像识别工具正被用于在低技能环境中更一致地解读横向流动化验。这些技术进步对于将筛检扩大到弱势群体和行动医疗单位至关重要。

哪里使用免疫测量检测梅毒成长最快？

高成长市场包括撒哈拉以南非洲、东南亚和拉丁美洲，这些地区的梅毒发生率高，医疗体係也正在现代化。公共卫生倡议正积极向社区诊所、行动医疗机构和孕产妇保健计画分发快速检测套组，以促进早期诊断并减少传播。

在开发中国家，常规筛检建议扩展到高风险族群，推动了性健康诊所、血库和惩教机构对实验室免疫测量的需求。包括远端医疗和家庭检测机构在内的私营部门也将免疫检测纳入直接向消费者提供的性传染感染检测套件中。这些采用管道正在提高梅毒免疫测量测定诊断在全球医疗保健机构中的普及率和效用。

梅毒免疫测量诊断市场的成长受到多种因素的推动。

梅毒免疫测量诊断市场的成长得益于全球性传染感染病例的不断增加、免疫测量灵敏度和便携性的提高，以及公共卫生部门对早期筛检和大规模筛检日益严格的要求。自动化高通量平台与临床实验室的整合，正在简化大规模筛检工作。

快速週转的即时免疫检测支持偏远和服务不足地区的诊断，尤其是在孕产妇和新生儿健康计画中。多重平台数位化检测解读工具的成长正在提高检测准确性和业务效率。此外，对感染疾病监测和国际援助计画的投资增加，正在扩大全球范围内获得价格合理、品质有保证的诊断试剂套件的管道。

部分

产品（分析仪、套件和试剂）；技术（CLIA、ELISA）；最终用途（血库最终用途、诊断实验室最终用途、医院最终用途、其他最终用途）

受访公司范例

• Abbott Laboratories
• AccuQuik（Jal Medical）
• Becton, Dickinson & Company（BD）
• bioMerieux SA
• Bio-Rad Laboratories
• Chembio Diagnostic Systems
• Danaher Corporation（Beckman Coulter）
• DiaSorin SpA
• Fujirebio
• New Industries Biomedical Engineering（SNIBE）
• NOWDiagnostics（NOWDx）
• QuidelOrtho Corporation
• Roche Diagnostics（F. Hoffmann-La Roche）
• Sekisui Chemical Co., Ltd.
• Shenzhen New Industries Biomedical Engineering Co., Ltd.
• Siemens Healthineers AG
• Stanbio（Sekisui Specialty Diagnostics）
• Thermo Fisher Scientific, Inc.
• Trinity Biotech

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Syphilis Immunoassay Diagnostics Market to Reach US$445.1 Million by 2030

The global market for Syphilis Immunoassay Diagnostics estimated at US$356.6 Million in the year 2024, is expected to reach US$445.1 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Analyzer, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$261.1 Million by the end of the analysis period. Growth in the Kit & Reagent segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$97.1 Million While China is Forecast to Grow at 6.8% CAGR

The Syphilis Immunoassay Diagnostics market in the U.S. is estimated at US$97.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$89.0 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Syphilis Immunoassay Diagnostics Market - Key Trends & Drivers Summarized

Why Are Immunoassay-Based Tests Becoming Central to Syphilis Diagnosis?

Syphilis immunoassay diagnostics have become a cornerstone in sexually transmitted infection (STI) screening due to their high specificity, scalability, and ability to detect both active and latent infections. These assays, which rely on antigen-antibody binding to detect Treponema pallidum, are employed across hospitals, sexual health clinics, and public health labs for routine and confirmatory testing. Their growing use is especially significant given the global resurgence of syphilis, including among high-risk populations and co-infected individuals with HIV.

Rapid point-of-care immunoassays are being adopted in decentralized healthcare settings, enabling faster treatment decisions, particularly in resource-limited regions. Automated immunoassay analyzers have become standard in centralized labs, offering high-throughput, multiplex testing alongside other STIs. Their integration into antenatal screening programs has also made them essential in preventing congenital syphilis. With increasing policy emphasis on early detection and treatment, immunoassay diagnostics now form the front line in syphilis control efforts worldwide.

How Is Technology Elevating Syphilis Immunoassay Diagnostic Accuracy and Reach?

The evolution of immunoassay platforms has significantly improved analytical performance. Chemiluminescent immunoassays (CLIA), enzyme-linked immunosorbent assays (ELISA), and fluorescence-based systems now offer superior sensitivity and specificity across different disease stages. Dual treponemal and non-treponemal antibody detection formats are being integrated to reduce false negatives and enable comprehensive serological profiling.

Miniaturization and microfluidics are enabling rapid immunoassays on handheld devices that deliver results within minutes without lab infrastructure. Multiplex immunoassays are being developed to test syphilis alongside HIV and hepatitis in a single cartridge. Additionally, AI-powered image recognition tools are being used to interpret lateral flow assays with greater consistency in low-skill settings. These technological advances are crucial for scaling up screening in vulnerable populations and in mobile healthcare units.

Where Is Immunoassay Adoption Increasing Most Rapidly for Syphilis Detection?

High-growth markets include sub-Saharan Africa, Southeast Asia, and Latin America-regions where syphilis prevalence is high and healthcare systems are undergoing diagnostic modernization. Public health initiatives are actively distributing rapid test kits in community clinics, mobile units, and maternal health programs to facilitate early diagnosis and reduce transmission.

Developed nations are expanding routine screening recommendations for high-risk groups, driving demand for lab-based immunoassays in sexual health clinics, blood banks, and correctional facilities. The private sector, including telehealth and at-home testing providers, is also incorporating immunoassays into direct-to-consumer STI kits. Together, these adoption channels are widening the reach and utility of syphilis immunoassay diagnostics across global health landscapes.

The Growth in the Syphilis Immunoassay Diagnostics Market Is Driven by Several Factors…

It is driven by the global rise in STI cases, advances in immunoassay sensitivity and portability, and increasing public health mandates for early and mass screening. The integration of automated, high-throughput platforms in clinical laboratories is streamlining large-scale screening efforts.

Point-of-care immunoassays with rapid turnaround are supporting diagnostics in remote or underserved regions, particularly within maternal and neonatal health programs. The growth of multiplex platforms and digitized assay interpretation tools is improving test accuracy and operational efficiency. Additionally, increased investment in infectious disease surveillance and international aid programs is expanding access to affordable, quality-assured diagnostic kits worldwide.

SCOPE OF STUDY:

The report analyzes the Syphilis Immunoassay Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Analyzer, Kit & Reagent); Technology (CLIA, ELISA); End-Use (Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AccuQuik (Jal Medical)
• Becton, Dickinson & Company (BD)
• bioMerieux SA
• Bio-Rad Laboratories
• Chembio Diagnostic Systems
• Danaher Corporation (Beckman Coulter)
• DiaSorin S.p.A.
• Fujirebio
• New Industries Biomedical Engineering (SNIBE)
• NOWDiagnostics (NOWDx)
• QuidelOrtho Corporation
• Roche Diagnostics (F. Hoffmann-La Roche)
• Sekisui Chemical Co., Ltd.
• Shenzhen New Industries Biomedical Engineering Co., Ltd.
• Siemens Healthineers AG
• Stanbio (Sekisui Specialty Diagnostics)
• Thermo Fisher Scientific, Inc.
• Trinity Biotech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Syphilis Immunoassay Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Syphilis Infections Drives Demand for Accurate Diagnostic Solutions
  • Increased Focus on Early Detection and Screening Programs Expands Use of Immunoassay Tests
  • Advancements in Rapid Point-of-Care Immunoassay Kits Enhance Testing Accessibility
  • Integration of Syphilis Screening Into Routine Antenatal Care Programs Spurs Market Growth
  • Technological Innovation in CLIA and ELISA Platforms Improves Test Sensitivity and Specificity
  • Demand for Multiplex STI Panels Including Syphilis Accelerates Test Consolidation in Labs
  • Growth in Public Health Funding for STI Control Drives Immunoassay Procurement
  • Increased Testing Compliance Mandates in High-Risk Populations Strengthens Diagnostic Uptake
  • Expansion of Sexual Health Clinics and Outreach Programs Fuels Volume-Based Test Adoption
  • Migration Trends and Urbanization Create New Testing Needs in Emerging Economies
  • Rise in Asymptomatic Infections Supports Use of Immunoassays for Population-Wide Surveillance
  • Digital Integration With Laboratory Information Systems Enhances Workflow and Result Management
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Syphilis Immunoassay Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Analyzer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Kit & Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Kit & Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Kit & Reagent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for CLIA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for CLIA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for CLIA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Blood Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Blood Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Blood Bank End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Lab End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostic Lab End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Diagnostic Lab End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION